Clinical trials recruiting in Sichuan, China

Phase breakdown

Conditions recruiting in Sichuan, China

Recruiting trials in Sichuan, China

• A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
  NCT06662786 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
  NCT06952803 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male
• A Study of YL202 in Combination With Other Anti-tumor Therapies in Patients With Advanced Solid Tumors
  NCT07169994 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female)
• China Colorectal Cancer Screening Trial 1 (C-Cost1)
  NCT07090291 · Phase: Not applicable (e.g. observational or device study) · Ages: 45 Years to 74 Years · Sex: All (male and female)
• Chinese Psoriasis Real World Evidence Research
  NCT04465838 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female)
• Effect of Lidocaine on Postoperative Pain and Long-term Survival in Elderly Patients Undergoing Colorectal Surgery
  NCT06405776 · Phase: Not applicable (e.g. observational or device study) · Ages: 60 Years and older · Sex: All (male and female)
• Evaluating the Preliminary Efficacy and Safety of JS207 in NSCLC After Progression Following Platinum-based Chemotherapy and Immunotherapy
  NCT06924606 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female)
• Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
  NCT05696626 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Lecanemab for Early Onset Familial Alzheimer's Disease
  NCT06883019 · Phase: Not specified · Ages: 18 Years to 65 Years · Sex: All (male and female)
• Multicenter, Phase II Randomized Controlled Study of Adebrelimab Combined With Chemotherapy and Concurrent Low-Dose Radiotherapy (LDRT) for the Treatment of Extensive-Stage Small Cell Lung Cancer (SCLC)
  NCT06610734 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female)
• Phase II Study of Irinotecan Liposomes in First-line Treatment of Metastatic Colorectal Cancer
  NCT06341296 · Phase: Phase 2 · Ages: 18 Years to 85 Years · Sex: All (male and female)
• SBRT Combined With PD-1 Inhibitor and Chemotherapy in Early-stage TNBC
  NCT06627712 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: Female
• The Prevalence of COPD in Patients With Cardiovascular Disease and the Benefit of Cardiopulmonary Co-management
  NCT06909773 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years and older · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Sichuan, China?

13 recruiting trials have at least one study site in Sichuan, China.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.